<VariationArchive VariationID="667398" VariationName="NM_033305.3(VPS13A):c.6283del (p.Ser2095fs)" VariationType="Deletion" Accession="VCV000667398" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2019-08-26" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="654549" VariationID="667398">
      <GeneList>
        <Gene Symbol="VPS13A" FullName="vacuolar protein sorting 13 homolog A" GeneID="23230" HGNC_ID="HGNC:1908" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="77177534" stop="77421537" display_start="77177534" display_stop="77421537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="79792360" stop="80032398" display_start="79792360" display_stop="80032398" Strand="+" />
          </Location>
          <OMIM>605978</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_033305.3(VPS13A):c.6283del (p.Ser2095fs)</Name>
      <CanonicalSPDI>NC_000009.12:77337440:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="77337441" stop="77337441" display_start="77337441" display_stop="77337441" variantLength="1" positionVCF="77337440" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="79952357" stop="79952357" display_start="79952357" display_stop="79952357" variantLength="1" positionVCF="79952356" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>S2095fs</ProteinChange>
      <ProteinChange>S2056fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.79952358del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.79952358del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.77337442del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.77337442del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008931.1" sequenceAccession="NG_008931" sequenceVersion="1" change="g.164998del">
            <Expression>NG_008931.1:g.164998del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018037.2" sequenceAccession="NM_001018037" sequenceVersion="2" change="c.6166del">
            <Expression>NM_001018037.2:c.6166del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018047.1" sequenceAccession="NP_001018047" sequenceVersion="1" change="p.Ser2056fs">
            <Expression>NP_001018047.1:p.Ser2056fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018038.3" sequenceAccession="NM_001018038" sequenceVersion="3" change="c.6283del">
            <Expression>NM_001018038.3:c.6283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001018048.1" sequenceAccession="NP_001018048" sequenceVersion="1" change="p.Ser2095fs">
            <Expression>NP_001018048.1:p.Ser2095fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015186.4" sequenceAccession="NM_015186" sequenceVersion="4" change="c.6283del">
            <Expression>NM_015186.4:c.6283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056001.1" sequenceAccession="NP_056001" sequenceVersion="1" change="p.Ser2095fs">
            <Expression>NP_056001.1:p.Ser2095fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_033305.3" sequenceAccession="NM_033305" sequenceVersion="3" change="c.6283del" MANESelect="true">
            <Expression>NM_033305.3:c.6283del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_150648.2" sequenceAccession="NP_150648" sequenceVersion="2" change="p.Ser2095fs">
            <Expression>NP_150648.2:p.Ser2095fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1587612257" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_033305.3(VPS13A):c.6283del (p.Ser2095fs) AND Chorea-acanthocytosis" Accession="RCV000826154" Version="4">
        <ClassifiedConditionList TraitSetID="1286">
          <ClassifiedCondition DB="MedGen" ID="C0393576">Chorea-acanthocytosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-09-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_033305.3(VPS13A):c.6283del (p.Ser2095fs) AND not provided" Accession="RCV002538244" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-22" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-08-26" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12404112</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21598378</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1286" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="805" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Acanthocytosis with neurologic disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Levine-Critchley syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Chorea-acanthocytosis</ElementValue>
                <XRef ID="MONDO:0008695" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Choreaacanthocytosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Choreoacanthocytosis</ElementValue>
                <XRef ID="Choreoacanthocytosis/1384" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CHAC</ElementValue>
                <XRef ID="GTR000501217" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="200150" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Chorea-acanthocytosis (ChAc) is characterized by a progressive movement disorder, cognitive and behavior changes, a myopathy that can be subclinical, and chronic hyperCKemia in serum. Although the disorder is named for acanthocytosis of the red blood cells, this feature is variable. The movement disorder is mostly limb chorea, but some individuals present with parkinsonism. Dystonia is common and affects the oral region and especially the tongue, causing dysarthria and serious dysphagia with resultant weight loss. Habitual tongue and lip biting are characteristic, as well as tongue protrusion dystonia. Progressive cognitive and behavioral changes resemble those in a frontal lobe syndrome. Seizures are observed in almost half of affected individuals and can be the initial manifestation. Myopathy results in progressive distal muscle wasting and weakness. Mean age of onset in ChAc is about 30 years, although ChAc can develop as early as the first decade or as late as the seventh decade. It runs a chronic progressive course and may lead to major disability within a few years. Life expectancy is reduced, with age of death ranging from 28 to 61 years.</Attribute>
                <XRef ID="NBK1387" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3956" />
                <XRef ID="3956" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301561</ID>
                <ID Source="BookShelf">NBK1387</ID>
              </Citation>
              <XRef ID="2388" DB="Orphanet" />
              <XRef ID="C0393576" DB="MedGen" />
              <XRef ID="MONDO:0008695" DB="MONDO" />
              <XRef Type="MIM" ID="200150" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1895483" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="91066864|Orphanet:ORPHA2388" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000967689" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12404112</ID>
          </Citation>
          <Comment>The p.Ser2095GlnfsX10 variant in VPS13A has been reported in one individual with chorea-acanthocytosis in the compound heterozygote state (phase not confirmed) with another loss of function variant (Dobson-Stone 2002). It was absent from la rge population studies. This variant is predicted to cause a frameshift, which a lters the protein?s amino acid sequence beginning at position 2095 and leads to a premature termination codon 10 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the VPS 13A gene is an established disease mechanism in autosomal recessive chorea-acant hocytosis. In summary, this variant meets criteria to be classified as pathogeni c for autosomal recessive chorea-acanthocytosis based on case observations, abse nce from controls, and predicted impact on protein. ACMG/AMP criteria applied: P VS1, PM2, PM3_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS13A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_033305.2:EXON 47</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_033305.2:c.6283delT</Name>
            <Name>p.Ser2095GlnfsX10</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.79952358delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Choreoacanthocytosis</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA2388" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5955212" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="267824|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003264605" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12404112</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12404112</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21598378</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 667398). This premature translational stop signal has been observed in individual(s) with choreoacanthocytosis (PMID: 12404112). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser2095Glnfs*10) in the VPS13A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in VPS13A are known to be pathogenic (PMID: 12404112, 21598378).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="VPS13A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.79952357del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1895483" TraitType="Disease" MappingType="Name" MappingValue="Choreoacanthocytosis" MappingRef="Preferred">
        <MedGen CUI="C0393576" Name="Chorea-acanthocytosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5955212" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

